DFD 03

Drug Profile

DFD 03

Alternative Names: DFD03

Latest Information Update: 04 Jan 2017

Price : $50

At a glance

  • Originator Dr Reddys Laboratories
  • Class Small molecules
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Acne vulgaris

Most Recent Events

  • 21 Nov 2016 Dr.Reddy's completed a phase II trial in Acne vulgaris in Germany (Topical) (EudraCT2015-004765-90)
  • 01 Feb 2016 Phase-II clinical trials in Acne vulgaris in Germany (Topical) (EudraCT2015-004765-90)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top